Bevacizumab, Doxorubicin, and Cyclophosphamide Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab in Treating Patients Who Have Undergone Surgery for Early-Stage Breast Cancer
NA
RATIONALE: Monoclonal antibodies, such as bevacizumab, can block tumor grow...
Background:
Data are scarce concerning injecting drug use (IDU) and alcoho...
Status
Unknown
Location
Multiple Locations
Start Date
2015-09
Trial ID
NCT02356185
Genetically Engineered Cells (MAGE-A1-specific T Cell Receptor-transduced Autologous T-cells) and Atezolizumab for the Treatment of Metastatic Triple Negative Breast Cancer, Urothelial Cancer, or Non-small Cell Lung Cancer
PHASE1
This phase I/II trial investigates the side effects of genetically engineer...
Status
Terminated
Location
Fred Hutch/University of Washington Cancer Consortium